INTEGRIN ANTAGONISTS - Patent 0946164

(19)

(11)

EP 0 946 164 A1

(12)

(43)	Date of publication:
	06.10.1999 Bulletin 1999/40

(21)	Application number: 97913775.0

(22)	Date of filing: 27.10.1997

(51)

International Patent Classification (IPC):

A61K 31/ 18^{( . )}
A61K 31/ 195^{( . )}
A61K 31/ 4375^{( . )}
A61K 31/ 505^{( . )}
A61P 9/ 10^{( . )}
A61P 27/ 02^{( . )}
A61P 35/ 00^{( . )}
C07D 213/ 73^{( . )}
C07D 239/ 12^{( . )}
C07D 239/ 42^{( . )}

A61K 31/ 192^{( . )}
A61K 31/ 437^{( . )}
A61K 31/ 44^{( . )}
A61P 9/ 00^{( . )}
A61P 19/ 10^{( . )}
A61P 29/ 00^{( . )}
A61P 43/ 00^{( . )}
C07D 213/ 74^{( . )}
C07D 239/ 14^{( . )}
C07D 471/ 04^{( . )}

(86)	International application number:
	PCT/US1997/019349

(87)	International publication number:
	WO 1998/018461 (07.05.1998 Gazette 1998/18)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

30.10.1996 US 19960029223P
18.12.1996 GB 19960026308

(71)	Applicant: MERCK & CO., INC.
	Rahway, New Jersey 07065 (US)

(72)	Inventors:
	DUGGAN, Mark, E. Rahway, NJ 07065 (US) HARTMAN, George, D. Rahway, NJ 07065 (US) HOFFMAN, William, F. Rahway, NJ 07065 (US) IHLE, Nathan, C. Rahway, NJ 07065 (US)

(74)	Representative: Hiscock, Ian James, et al
	European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR Harlow, Essex CM20 2QR (GB)

(54)	INTEGRIN ANTAGONISTS